495 studies found for:    "Anemia, Hemolytic, Congenital"
Show Display Options
Rank Status Study
1 Recruiting Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
Conditions: Congenital Hemolytic Anemia;   Diamond-Blackfan Anemia
Interventions: Procedure: Radiotherapy;   Drug: Alemtuzumab (Campath  );   Drug: Sirolimus (Rapamune  )
2 Recruiting Pyruvate Kinase Deficiency Natural History Study
Conditions: Pyruvate Kinase Deficiency;   Congenital Non-Spherocytic Hemolytic Anemia
Intervention:
3 Terminated The Dallas Hereditary Spherocytosis Cohort Study
Condition: Hereditary Spherocytosis
Intervention:
4 Completed Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound
Condition: Sickle Cell Disease
Interventions: Procedure: Hematopoietic Stem Cell Transplantation;   Device: CliniMACS;   Drug: See intervention description
5 Recruiting Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
Condition: Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
Interventions: Drug: Montelukast added to Hydroxyurea;   Drug: Placebo added to Hydroxyurea
6 Unknown  Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both
Condition: Thalassemia
Interventions: Drug: Deferoxamine;   Drug: Deferasirox
7 Withdrawn Treatment of Iron Overload Requiring Chelation Therapy
Conditions: Transfusional Iron Overload;   Iron Overload;   Iron Chelation;   Beta-thalassemia;   Transfusional Hemosiderosis;   Iron Metabolism Disorders;   Metabolic Diseases
Interventions: Drug: SPD602;   Drug: Deferasirox
8 Completed Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program
Condition: Sickle Cell Disease
Intervention: Other: Assessment
9 Active, not recruiting Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations
Conditions: Thalassemia;   Sickle Cell Disease;   Myelodysplasia
Intervention: Biological: Blood sample
10 Completed A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
Conditions: Beta-Thalassemia;   Hemosiderosis
Intervention: Drug: deferasirox
11 Recruiting Unrelated Umbilical Cord Blood Following HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients With β-thalassemia Major
Condition: Thalassemia Major
Intervention: Genetic: unrelated CB following haplo-identical hematopoietic stem cells transplantation
12 Withdrawn Dipyridamole/Magnesium To Improve Sickle Cell Hydration
Condition: Anemia, Sickle Cell
Intervention: Drug: oral dipyridamole, oral magnesium, or a combination of both
13 Recruiting Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Simvastatin
14 Not yet recruiting Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease
Condition: Sickle Cell Disease
Interventions: Drug: Hydromorphone (Standardized, weight-based dosing);   Drug: Morphine Sulfate (Standardized, weight-based dosing);   Drug: Hydromorphone (Patient Specific dosing);   Drug: Morphine Sulfate (Patient Specific dosing)
15 Recruiting Liver Fibrosis in Sickle Cell Disease
Condition: Sickle Cell Disease
Interventions: Other: Liver transient elastography (Fibroscan);   Other: Ferriscan;   Procedure: Liver biopsy
16 Completed Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Sickle Cell Disease;   Thalassemia
Intervention: Drug: L-Glutamine
17 Recruiting Retroviral Vector Mediated Globin Gene Transfer to Correct Sickle Cell Anemia or Thalassemia
Conditions: Sickle Cell Anemia;   Thalassemia
Intervention: Genetic: Gene Therapy
18 Recruiting Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency
Conditions: G6PD Normal;   G6PD Deficient;   Healthy
Intervention: Drug: Regimens (Primaquine, Methylene blue)
19 Completed
Has Results
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
Condition: Thalassemia
Intervention:
20 Completed Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Conditions: Sickle Cell Disease;   Vaso-occlusive Crisis;   Pain Crisis
Interventions: Drug: GMI-1070;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years